Artificial Intelligence has helped scientists reveal a new form of aggressive prostate cancer which could revolutionise how the disease is diagnosed and treated in the future.

A Cancer Research UK-funded study reveals that prostate cancer, which affects one in eight men in their lifetime, includes two different subtypes termed evotypes.

An international team of scientists led by ICREA researcher and Director of the Life Sciences Department at the Barcelona Supercomputing Centre - Centro Nacional de Supercomputación (BSC-CNS), Alfonso Valencia, has developed a technology based on artificial intelligence (AI) for the study of minority diseases and has successfully applied it to identify the possible causes of the appearance of what are known as myasthenic-congenital syndromes, a group of rare inherited disorders that limit the ability to move and cause varying degrees of muscle weakness in patients.

Better prevention of Type II diabetes could save both lives and money. The U.S. spends over $730 billion a year - nearly a third of all health care spending - on treating preventable diseases like diabetes.

For the 98 million adults who are prediabetic and at risk of developing Type II diabetes, preventive treatments such as the drug metformin can help stave off the disease.

A large language model (LLM) artificial intelligence (AI) system can match, or in some cases outperform, human ophthalmologists in the diagnosis and treatment of patients with glaucoma and retina disease, according to research from New York Eye and Ear Infirmary of Mount Sinai (NYEE).

The provocative study, published February 22, in JAMA Ophthalmology, suggests that advanced AI tools, which are trained on vast amounts of data, text, and images,

Medical summarization, a process that uses artificial intelligence (AI) to condense complex patient information, is currently used in health care settings for tasks such as creating electronic health records and simplifying medical text for insurance claims processing. While the practice is intended to create efficiencies, it can be labor-intensive, according to Penn State researchers, who created a new method to streamline the way AI creates these summaries, efficiently producing more reliable results.

A UCL-developed app that provides speech therapy for people with the language disorder aphasia has been found to significantly improve their ability to talk.

iTalkBetter, developed by the Neurotherapeutics Group at the UCL Queen Square Institute of Neurology, provides users the digital platform to practice over 200 commonly used words, in their own time and without any limits on the amount of therapy they receive.

A team of pediatric clinicians at Mass General Brigham have turned to generative artificial intelligence (AI) to tackle problems plaguing child medical care delivery in resource-poor countries that increase risk for poor outcomes and mortality.

The clinicians developed a series of 45 multilingual videos, each ranging from 3 to 8 minutes long, designed to educate providers around the world on pediatric care topics touching on teamwork,